Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Roll out of second vaccine a 'triumph of British science'- UK's Hancock

Mon, 04th Jan 2021 07:14

LONDON, Jan 4 (Reuters) - The roll-out of the
AstraZeneca-Oxford University Covid-19 vaccine from Monday was a
"triumph of British science" that would be the only long-term
way out of the pandemic, British Health Secretary Matt Hancock
said.

"We obviously have the very positive news this morning of
the Oxford vaccine starting to be rolled out," he told Sky News
on Monday. "That's a triumph of British science that we've
managed to get were we are."

Hancock said Britain had already delivered 1 million shots
of the Pfizer-BioNTech vaccine, which was more than the rest of
Europe combined.
(Reporting by Guy Faulconbridge and Kate Holton, Writing by
Paul Sandle)

Related Shares

More News
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.